More on PHAR
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $12.82 |
|
|||
| Open | $12.76 | ||||
| 52 Wk High | $0.00 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $13.25 | ||||
| Day Low | $10.00 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 12,119 | ||||
- Form 6-K Pharming Group N.V. For: Sep 25
- Pharming Group to participate in September investor conferences
- Form 6-K Pharming Group N.V. For: Aug 14
- Form 6-K Pharming Group N.V. For: Aug 09
- Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
- Form 6-K Pharming Group N.V. For: Aug 03
- Form 6-K Pharming Group N.V. For: Jul 18
- Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board
- Pharming Group to report second quarter and first half 2023 financial results on August 3
- Sequana Medical announces results of Special General Meeting of Shareholders
Entities mentioned with PHAR
- FDA | View Related Stories »
- PDUFA | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Earnings | View Related Stories »
- Visium Asset Management | View Related Stories »
- Equity Offerings | View Related Stories »
- Genzyme/Sanofi-Aventis | View Related Stories »
- Wells Fargo | View Related Stories »
- Show More...
